Intrathecal morphine combined with transverse abdominal fascia nerve block for postoperative analgesia after cesarean section in severe preeclampsia: a randomized controlled trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100054293

Enrollment

Unknown

Registered

2021-12-13

Start date

2021-12-14

Completion date

Unknown

Last updated

2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe eclampsia

Interventions

Experimental group:intrathecal injection of morphine combined with transverse abdominal tendon plane nerve block

Control group:transverse abdominal tendon plane nerve block

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. In line with the eighth edition of the diagnostic criteria for obstetrics and gynecology, ASA grade II; 2. 35-39 weeks of pregnancy, singleton; 3. Antispasmodic, antihypertensive and other treatments were given before operation, blood pressure was controlled at 160-120/100-80 mm Hg, and heart rate was 60-120 beats/min.

Exclusion criteria

Exclusion criteria: BMI>40kg/m^2, fetal distress, contraindications to regional anesthesia or spinal anesthesia, allergic to opioids.

Design outcomes

Primary

Measure	Time frame
visual analogue scale;	—

Countries

China

Contacts

Public ContactYan Zhirong

Fujian Maternal and Child Health Hospital, Fujian Medical University Affiliated Hospital

dr_zr.yan@hotmail.com+86 13950319086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026